Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
As a science-led global healthcare company, GSK’s key priority is to continue the manufacture and supply of medicines and vaccines in the UK, support the NHS and ensure the safety and well-being of our employees, customers and patients. Our teams are on hand to support with queries you may have.
GSK’s response to COVID-19
In an unprecedented collaboration, GSK has joined forces with Sanofi to bring together two of the world’s largest vaccines companies to fight COVID-19. The collaboration will combine the scientific and manufacturing expertise and resources of two global scale vaccines specialists to develop a new, adjuvanted vaccine.
Need to get in touch?
If you require further information, please contact us:
Alongside this, in the global search for potential COVID-19 medicines, we are evaluating our marketed pharmaceutical products and medicines in development to determine if any could be used beyond their current indications in response to the pandemic.
We are also supporting a range of global and local initiatives. This includes our $10m donation to the World Health Organisation and UN Foundation’s COVID-19 Solidarity Response Fund, as well as partnerships to make our vaccines adjuvant technology available in multiple COVID-19 vaccine research programmes.
For patients who have been identified by the Government as vulnerable, such as those with severe asthma, we are helping by enabling self-administration at home. This allows them to follow Government advice to stay home where possible, whilst continuing to access the care and medicines they need.
GSK resources
We have a range of resources to support healthcare professionals and patients with their respiratory health at this time:
- GSK product information (contains promotional content).
- Free patient support items, including demo devices and placebos (contains promotional content).
- Remote review hub, offers the tools and resources you need to confidently review your respiratory patients and manage their treatment remotely.
- Oncology Expert Insights, a podcast and webinar series on the latest developments in ovarian cancer management (contains promotional content).
Supply of medicines
Stay up to date on the availability of our medicines and vaccines in the UK by visiting our supply page.
Other resources and useful information for healthcare professionals
The NHS and its partners are undertaking tremendous work to tackle the COVID-19 challenge. This is putting pressure on all NHS services. Patients may require support and advice from their local healthcare professionals. As such we understand that it may be helpful to provide useful links to further information.
The following organisations have published relevant guidance on COVID-19 for healthcare professionals and patients:
| UK | |
|---|---|
RCP |
|
RCGP |
|
BTS |
https://www.brit-thoracic.org.uk/about-us/covid-19-information-for-the-respiratory-community/ |
PCRS |
|
NICE |
|
Royal Pharmaceutical Society |
|
PCPA |
|
RCN |
|
ARNS |
|
UKIG inhaler techniques |
https://ukiginhalerstandards.educationforhealth.org/ukig-standards/ |
BLF |
|
Asthma UK |
|
Royal College of Physicians and Surgeons of Glasgow |
https://rcpsg.ac.uk/college/covid-19/ |
Need to get in touch?
If you require further information, please contact us:
- UK Customer Contact Centre
- Live chat
- Freephone: 0800 221 441
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.
